EE9900540A - Omeprasooli ravimvorm - Google Patents

Omeprasooli ravimvorm

Info

Publication number
EE9900540A
EE9900540A EEP199900540A EEP9900540A EE9900540A EE 9900540 A EE9900540 A EE 9900540A EE P199900540 A EEP199900540 A EE P199900540A EE P9900540 A EEP9900540 A EE P9900540A EE 9900540 A EE9900540 A EE 9900540A
Authority
EE
Estonia
Prior art keywords
dosage form
omeprazole dosage
omeprazole
dosage
Prior art date
Application number
EEP199900540A
Other languages
English (en)
Inventor
Erickson Magnus
Josefsson Lars
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9900540(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900540A publication Critical patent/EE9900540A/et
Publication of EE03903B1 publication Critical patent/EE03903B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
EEP199900540A 1997-05-28 1998-05-18 Omeprasooli ravimvorm EE03903B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702000A SE9702000D0 (sv) 1997-05-28 1997-05-28 New pharmaceutical formulation
PCT/SE1998/000922 WO1998053803A1 (en) 1997-05-28 1998-05-18 Pharmaceutical formulation of omeprazole

Publications (2)

Publication Number Publication Date
EE9900540A true EE9900540A (et) 2000-06-15
EE03903B1 EE03903B1 (et) 2002-12-16

Family

ID=20407122

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900540A EE03903B1 (et) 1997-05-28 1998-05-18 Omeprasooli ravimvorm

Country Status (41)

Country Link
US (1) US6090827A (et)
EP (1) EP0984773B1 (et)
JP (1) JP4649001B2 (et)
KR (1) KR100540721B1 (et)
CN (1) CN1123338C (et)
AR (1) AR012698A1 (et)
AT (1) ATE234078T1 (et)
AU (1) AU722879B2 (et)
BR (1) BR9809484A (et)
CA (1) CA2290531C (et)
CZ (1) CZ298972B6 (et)
DE (1) DE69812089T2 (et)
DK (1) DK0984773T3 (et)
DZ (1) DZ2494A1 (et)
EE (1) EE03903B1 (et)
EG (1) EG24044A (et)
ES (1) ES2195342T3 (et)
HK (1) HK1025744A1 (et)
HR (1) HRP980260B1 (et)
HU (1) HU229154B1 (et)
ID (1) ID24654A (et)
IL (1) IL132895A0 (et)
IS (1) IS2856B (et)
MA (1) MA26497A1 (et)
MY (1) MY122298A (et)
NO (1) NO328100B1 (et)
NZ (1) NZ500886A (et)
PL (1) PL194634B1 (et)
PT (1) PT984773E (et)
RS (1) RS49629B (et)
RU (1) RU2207121C2 (et)
SA (1) SA98190304B1 (et)
SE (1) SE9702000D0 (et)
SI (1) SI0984773T1 (et)
SK (1) SK286625B6 (et)
TN (1) TNSN98068A1 (et)
TR (1) TR199902890T2 (et)
TW (1) TW575435B (et)
UA (1) UA71541C2 (et)
WO (1) WO1998053803A1 (et)
ZA (1) ZA984178B (et)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) * 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
CA2298823C (en) * 1998-04-20 2011-06-07 Eisai Co., Ltd. Stabilized composition comprising a benzimidazole type compound
SE9803772D0 (sv) 1998-11-05 1998-11-05 Astra Ab Pharmaceutical formulation
SE9902386D0 (sv) * 1999-06-22 1999-06-22 Astra Ab New formulation
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
TWI268779B (en) 1999-10-20 2006-12-21 Eisai Co Ltd Method for stabilizing benzimidazole-based compounds
US20040092511A1 (en) * 1999-12-10 2004-05-13 Billstein Stephan Anthony Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
JP2002234842A (ja) * 2001-02-09 2002-08-23 Kyowa Yakuhin Kogyo Kk 内服腸溶性製剤
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
FR2843121B3 (fr) 2002-08-02 2004-09-10 Rhodia Chimie Sa Agent ignifugeant, procede de preparation et l'utilisation de cet agent
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
AU2004208606B2 (en) 2003-01-29 2009-09-24 Takeda Pharmaceutical Company Limited Process for producing coated preparation
JP4567340B2 (ja) * 2003-01-29 2010-10-20 武田薬品工業株式会社 被覆製剤の製造方法
CN1761465B (zh) * 2003-01-29 2010-10-13 武田药品工业株式会社 制备被覆制剂的方法
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CN1311824C (zh) * 2004-04-21 2007-04-25 常州市第四制药厂有限公司 奥美拉唑肠溶微粒制剂及制备方法
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE602005013372D1 (de) * 2005-07-29 2009-04-30 Rottapharm Spa Kombination aus Itriglumid und PPI zur Behandlung von gastrointestinalen- und assozierten Krankheiten
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
KR101436516B1 (ko) * 2007-07-23 2014-09-02 주식회사태평양제약 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
CN101808622A (zh) * 2007-09-28 2010-08-18 西梯茜生命工学股份有限公司 含有埃索美拉唑的药物组合物
DK2273985T3 (en) * 2008-03-28 2016-04-25 Ferrer Int Capsule for the prevention of cardiovascular diseases
US8148414B2 (en) 2008-08-19 2012-04-03 Xenoport, Inc. Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
JP2015526477A (ja) 2012-08-22 2015-09-10 ゼノポート，インコーポレイティド メチル水素フマレートの経口剤形およびそのプロドラッグ
US10945984B2 (en) 2012-08-22 2021-03-16 Arbor Pharmaceuticals, Llc Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
CN102961356A (zh) * 2012-12-11 2013-03-13 山西云鹏制药有限公司 一种含奥美拉唑的蓝色肠溶片剂的制备方法
WO2014160633A1 (en) 2013-03-24 2014-10-02 Xenoport, Inc. Pharmaceutical compositions of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc （ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
WO2015042294A1 (en) * 2013-09-18 2015-03-26 Xenoport, Inc. Nanoparticle compositions of dimethyl fumarate
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2021153525A1 (ja) 2020-01-27 2021-08-05 東和薬品株式会社 エソメプラゾール経口製剤およびその製造方法
KR102432084B1 (ko) 2021-11-16 2022-08-12 알리코제약(주) S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH05255088A (ja) * 1991-11-05 1993-10-05 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
JP2669446B2 (ja) * 1992-03-23 1997-10-27 信越化学工業株式会社 医薬品コーティング液用原料粉粒体
JPH0733659A (ja) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
AU695966B2 (en) * 1994-07-08 1998-08-27 Astrazeneca Ab Multiple unit tableted dosage form I
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms

Also Published As

Publication number Publication date
BR9809484A (pt) 2000-06-20
CN1123338C (zh) 2003-10-08
NO995809L (no) 2000-01-28
MA26497A1 (fr) 2004-12-20
EE03903B1 (et) 2002-12-16
UA71541C2 (uk) 2004-12-15
RS49629B (sr) 2007-08-03
HUP0002182A2 (hu) 2002-05-29
HU229154B1 (en) 2013-09-30
NO995809D0 (no) 1999-11-26
SK159099A3 (en) 2000-06-12
NO328100B1 (no) 2009-12-07
ZA984178B (en) 1998-11-30
HRP980260A2 (en) 1999-02-28
NZ500886A (en) 2001-11-30
HK1025744A1 (en) 2000-11-24
SI0984773T1 (en) 2003-10-31
IL132895A0 (en) 2001-03-19
SE9702000D0 (sv) 1997-05-28
EP0984773B1 (en) 2003-03-12
JP2002500665A (ja) 2002-01-08
YU60899A (sh) 2002-06-19
ID24654A (id) 2000-07-27
CN1258217A (zh) 2000-06-28
CA2290531A1 (en) 1998-12-03
HUP0002182A3 (en) 2003-02-28
IS5245A (is) 1999-11-11
AU722879B2 (en) 2000-08-10
PL194634B1 (pl) 2007-06-29
RU2207121C2 (ru) 2003-06-27
EP0984773A1 (en) 2000-03-15
DE69812089D1 (de) 2003-04-17
TW575435B (en) 2004-02-11
CZ420299A3 (cs) 2000-05-17
CZ298972B6 (cs) 2008-03-26
US6090827A (en) 2000-07-18
WO1998053803A1 (en) 1998-12-03
KR20010013104A (ko) 2001-02-26
SA98190304B1 (ar) 2006-10-11
AU7680398A (en) 1998-12-30
HRP980260B1 (en) 2003-10-31
TR199902890T2 (xx) 2000-02-21
ES2195342T3 (es) 2003-12-01
DZ2494A1 (fr) 2003-01-25
ATE234078T1 (de) 2003-03-15
DK0984773T3 (da) 2003-07-07
CA2290531C (en) 2006-12-12
KR100540721B1 (ko) 2006-01-10
SK286625B6 (sk) 2009-02-05
EG24044A (en) 2008-04-13
TNSN98068A1 (fr) 2005-03-15
DE69812089T2 (de) 2004-03-04
MY122298A (en) 2006-04-29
PL337237A1 (en) 2000-08-14
JP4649001B2 (ja) 2011-03-09
IS2856B (is) 2013-11-15
PT984773E (pt) 2003-07-31
AR012698A1 (es) 2000-11-08

Similar Documents

Publication Publication Date Title
EE9900540A (et) Omeprasooli ravimvorm
IS5425A (is) Læknislyf
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
ATE321483T1 (de) Dose
IS5272A (is) Nýtt form S-ómeprasóls
NO20003640D0 (no) Ny doseringsform
DE69825982D1 (de) Spritze
ID27841A (id) Turunan-turunan biaril terapeutik
NO992692D0 (no) Nefadozon doseringsform
NO980546D0 (no) Farmasöytiske midler
EE200000022A (et) Uus ravimvorm
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
DE29817592U1 (de) Dose
EE9800209A (et) Antiglükokortikoidne ravimaine
DE29723167U1 (de) Reiheneinbaugerät
ID23531A (id) Komposisi farmasi
DE69812105D1 (de) Einnahmevorrichtungen
DE29713277U1 (de) Bohnenstangen-Set
DE29821753U1 (de) Dose
ID21180A (id) Senyawa-senyawa farmasi
BR1100755A (pt) composição farmacêutica
UA25523A (uk) Лікувальhий препарат гірчичhик
FR2771676B1 (fr) Livre
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160518